PATENT CLAIM ANALYSIS

Application Number: 15887076
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "522000"]

Abstract:
This invention provides substituted acylanilide compounds and uses thereof in treating a variety of diseases or conditions in a subject including, inter alia, a muscle wasting disease and/or disorder such as Duchenne muscular dystrophy or Becker muscular dystrophy.

Claim (Index 2):
The method of  claim 1 , wherein said method further increases the physical function of said subject.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 88.0
- Lexical Diversity: 1.20588
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15398672', '14963054', '15153690', '15786811', '15190732']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.838336088160904
- 35 USC 102 Novelty (BERT): 0.629414016564384
- Combined Prediction Score: 0.817443881001252
- Mean Citation Score: 493.939084
- Max Citation Score: 595.6595
- Similarity Product: 545.5362700362205

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test